Current Diagnostic And Management Strategies For Attr Amyloidosis

Current diagnostic and management strategies for ATTR amyloidosis

VJHemOnc – Video Journal of Hematology & HemOnc

Emerging strategies in the management of ATTR amyloidosis

Cardiology University of Washington

Treatment approaches for AL amyloidosis versus ATTR amyloidosis

VJHemOnc – Video Journal of Hematology & HemOnc

3D Video Understanding ATTR Amyloidosis

Amyloidosis Research Consortium (ARC)

Treatment and Management of Transthyretin-mediated (ATTR) Amyloidosis

Heart Failure Society of America

Cardiac Amyloidosis: Quick Tips on Amyloid-specific Therapy

American College of Cardiology

Ralph — Wild-Type Amyloidosis Patient

Amyloidosis Research Consortium (ARC)

FDA Approves Treatment for Transthyretin Amyloid Cardiomyopathy

Recent Advances in the Treatment of Hereditary ATTR Amyloidosis (hATTR)

Contemporary Strategies: Diagnosing ATTR Amyloidosis

The France Foundation

ARC Talks Webinar: Current ATTR landscape: Treatments and Trials

Amyloidosis Research Consortium (ARC)

Cardiac Amyloidosis No longer rare and untreatable - Bell-Ezziddine

Current status & updates in the management of AL amyloidosis

VJHemOnc – Video Journal of Hematology & HemOnc

Diagnosing ATTR-CM and Treatment Options

NUHCS: National University Heart Centre, Singapore

What's new and exciting in ATTR cardiac amyloidosis in 2024

Amyloidosis Foundation

Cardiac Amyloidosis: Quick Tips on Medical Management

American College of Cardiology

Cutting-Edge Updates in Cardiac Amyloidosis: What’s New for Patients

Cardiac Amyloidosis: Quick Tips on Nomenclature and Epidemiology

American College of Cardiology

Positive Data for Investigational Treatment for ATTR With Cardiomyopathy

Treatment frontiers in cardiac amyloidosis

Cardiomyopathy UK